At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 68 enrolled
Drug / intervention
Granisetron 0.1 MG/ML +1 moredrug
Likely dose
Granisetron 0.1 MG/MLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Attenuation of Spinal Induced Hypotension With Granisetron in Type I Diabetic Parturients
In Brief
A Phase 4 clinical trial evaluating Granisetron 0.1 MG/ML and Placebos for Spinal-induced Hypotension. Completed, enrolled 68 participants across 1 site.
Detailed Summary
Diabetic Parturients are exposed to intraoperative hypotension after spinal anesthesia and we proposed that intravenous Granisterone 1 mg will attenuate the hypotension occurred with spinal block during Cesarean sections.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal-induced Hypotension
CountriesEgypt
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedMar 2017
Enrollment StartMar 2018
Primary CompletionSep 2018
Study CompletionNov 2018
TodayJul 2026
First PostedMar 27, 2017
Enrollment StartMar 1, 2018
Primary CompletionSep 1, 2018
Study CompletionNov 1, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.3 years ago
Interventions
Granisetron 0.1 MG/MLdrug
Granisetron 0.1 MG/ML Will be given 10 min before spinal block
Placebosdrug
Placebos will be given 10 min before spinal block